Bionomics Provides Update on BNC105 and BNC210
Thu, 4 Feb 2010 12:30pm
BIONOMICS LIMITED (BNO)
Loading presentation... If nothing happens, you may need to install Flash and/or enable javascript in your browser.
Dr Deborah Rathjen
BNO Licensee, Ironwood submits IND Application for Anti-Anxiety Drug
Fri, 9 Nov 2012 11:45am
Deborah Rathjen, CEO
Dr Deborah Rathjen
Bionomics presents at the ASX Small to Mid Caps conference in Hong Kong
Tue, 30 Oct 2012 9:15am
Deborah Rathjen, Managing Director
Dr Deborah Rathjen
Bionomics to present at the upcoming ASX Small to Mid Caps conference in Hong Kong and Singapore
Tue, 2 Oct 2012 11:30am
Deborah Rathjen, Managing Director
Dr Deborah Rathjen
Bionomics investor update presentation
Mon, 17 Sep 2012 11:00am
Dr Deborah Rathjen, CEO & Managing Director
Dr Deborah Rathjen
Bionomics ltd BNC 105 Trial Data
Wed, 13 Jun 2012 9:00am
Deborah Rathjen, Managing Director
Dr Deborah Rathjen
Bionomics Limited presents at the ASX Small to Mid Caps conference in New York
Mon, 2 Apr 2012 1:00pm
Deborah Rathjen, CEO and Managing Director
Dr Deborah Rathjen
Bionomics targets Alzheimer`s Disease
Mon, 20 Feb 2012 11:05am
Dr Deborah Rathjen, Managing Director
Dr Deborah Rathjen
Bionomics 2011 Annual General Meeting
Fri, 11 Nov 2011 9:45am
Dr Deborah Rathjen, Managing Director, CEO
Dr Deborah Rathjen
Bionomics Limited - ASX Small to Mid Caps Conference in Singapore and Hong Kong
Fri, 4 Nov 2011 11:25am
Deborah Rathjen, Managing Director & CEO
Dr Deborah Rathjen
Bionomics to present at the ASX Small to Mid Caps conference in Hong Kong and Singapore
Thu, 6 Oct 2011 10:15am
Dr Deborah Rathjen, CEO
Icon_lastIcon_nextIcon_previousIcon_first